Off-label prescribing in psychiatric practice

Advances in Psychiatric Treatment

Volumn 13, Issue 6, 2007, Pages 414-422

  Baldwin, David S ^a,b   Kosky, Nick ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Hampshire Partnership Trust   (United Kingdom)

^c Melcombe Day Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE; FLUVOXAMINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PROPRANOLOL; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

AGITATION; AKATHISIA; ANXIETY DISORDER; AUTOMUTILATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DECISION MAKING; DELUSION; DEPRESSION; DRUG EFFICACY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; EXHIBITIONISM; HALLUCINATION; HEALTH CARE POLICY; HUMAN; LOW DRUG DOSE; MALPRACTICE; MEDICAL SOCIETY; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; OFF LABEL DRUG USE; PATIENT SAFETY; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHIZOPHRENIA; WANDERING BEHAVIOR;

EID: 38649093948     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.107.004184     Document Type: Review

References (43)

1. Adler, L., Angrist, B., Peselow, E., et al (1986) A controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia. British Journal of Psychiatry, 149, 42-45.
2. Anonymous (1992) Prescribing unlicensed drugs or using drugs for unlicensed indications. Drug and Therapeutics Bulletin, 30, 97-99.
3. Ansani, N., Sirio, C., Smitherman, T., et al (2006) Designing a strategy to promote safe, innovative off-label use of medications. American Journal of Medical Quality, 21, 255-261.
4. Barbui, C., Danese, A., Guaiana, G., et al (2002) Prescribing second-generation antipsychotics and the evolving standard of care in Italy. Pharmacopsychiatry, 35, 239-243.
5. Barnard, L., Young, A. H., Pearson, J., et al (2002) Systematic review of the use of atypical antipsychotics in autism. Journal of Psychopharmacology, 16, 93-101.
6. Beck, S., Paton, C., Euba, R., et al (2001) Atypical antipsychotics in the elderly. International Journal of Psychiatry in Clinical Practice, 5, 257-261.
7. Bellhouse, J., Holland, A., Clare, I., et al (2001) Decision-making capacity in adults: its assessment in clinical practice. Advances in Psychiatric Treatment, 7, 294-301.
8. Bradley, E. & Lofchy, J. (2005) Learning disability in the accident and emergency department. Advances in Psychiatric Treatment, 11, 45-57.
9. Bramble, D. (1992) The use of antidepressants by British child psychiatrists. Psychiatric Bulletin, 16, 396-398.
10. Bramble, D. (2003) The use of psychotropic medications in children: a British view. Journal of Child Psychology and Psychiatry, 44, 169-179.
11. British Association for Psychopharmacology (1997) BAP consensus statement. Child and learning disability psychopharmacology. Journal of Psychopharmacology, 11, 291-294.
12. British Medical Association & Royal Pharmaceutical Society of Great Britain (2007) British National Formulary (March issue). BMJ Publishing Group & RPS Publishing.
13. Bücheler, R., Schwab, M., Mörike, K., et al (2002) Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ, 324, 1311-1312.
14. Doerry, U. A. & Kent, L. (2003) Prescribing practices of community child and adolescent psychiatrists. Psychiatric Bulletin, 27, 407-410.
15. Douglas-Hall, P., Fuller, A. & Gill-Banham, S. (2001) An analysis of off-licence prescribing in psychiatric medicine. Pharmaceutical Journal, 267, 890-891.
16. Efron, D., Hiscock, H., Sewell, J. R., et al (2003) Prescribing of psychotropic medications for children by Australian paediatricians and child psychiatrists. Pediatrics, 111, 372-375.
17. Ekins-Daukes, S., Helms, P. J., Taylor, M. W., et al (2005) Off-label prescribing to children: attitudes and experience of general practitioners. British Journal of Clinical Pharmacology, 60, 145-149.
18. Garattini, S. & Bertele, V. (2005) The impact of European regulatory policies on psychotropic drug prescribing patterns. International Review of Psychiatry, 17, 199-204.
19. Gazarian, M., Kelly, M., McPhee, J. R., et al (2006) Off-label use of medicines: consensus recommendations for evaluating appropriateness. Medical Journal of Australia, 185, 544-548.
20. Haw, C. & Stubbs, J. (2005a) A survey of the off-label use of mood stabilizers in a large psychiatric hospital. Journal of Psychopharmacology, 19, 402-407.
21. Haw, C. & Stubbs, J. (2005b) A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness. Journal of Intellectual Disability Research, 49, 858-864.
22. Haw, C. & Stubbs, J. (2006) Benzodiazepines - a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital. Journal of Psychopharmacology, published online. doi:10.1177/ 0269881106072386.
23. Healy, D. & Nutt, D. (1998) Prescriptions, licence and evidence. Psychiatric Bulletin, 22, 680-684.
24. Hodgson, R. & Belgamwar, R. (2006) Off-label prescribing by psychiatrists. Psychiatric Bulletin, 30, 55-57.
25. Hugtenburg, J. G., Heerdink, E. R. & Tso, Y. H. (2005) Psychoactive drug prescribing by Dutch child and adolescent psychiatrists. Acta Paediatrica, 94, 1484-1487.
26. Kohen, D. (2004) Psychotropic medication in pregnancy. Advances in Psychiatric Treatment, 10, 59-66.
27. Lowe-Ponsford, F. & Baldwin, D. S. (2000) Off-label prescribing by psychiatrists. Psychiatric Bulletin, 24, 415-417.
28. McNicholas, F. (2001) Prescribing practices of child psychiatrists in the UK. Child Psychology and Psychiatry Review, 1, 94-97.
29. Milton, J., Lawton, J., Smith, M., et al (1998) Hidden high-dose antipsychotic prescribing: effects of p.r.n. doses. Psychiatric Bulletin, 22, 675-677.
30. Pogge, D. L., Young, K., Insalaco, B., et al (2007) Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay. International Journal of Clinical Practice, 61, 896-902.
31. Rosenheck, R., Leslie, D. & Sernyak, M. (2001) From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs. Medical Care, 39, 302-308.
32. Royal College of Paediatrics and Child Health (2000) The Use of Unlicensed Medicines or Licensed Medicines for Unlicensed Applications in Paediatric Practice. Policy Statement Produced by the Joint RCPCH/ NPPG Standing Committee on Medicines. Royal College of Paediatrics and Child Health.
33. Royal College of Psychiatrists (2006) Consensus Statement on High-Dose Antipsychotic Medication (Council Report CR138). Royal College of Psychiatrists.
34. Royal College of Psychiatrists (2007) Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice (College Report CR142). Royal College of Psychiatrists.
35. Rubin, P. C., Craig, G. F., Gavin, K., et al (1986) Prospective survey of use of therapeutic drugs, alcohol and cigarettes during pregnancy. BMJ, 292, 81-83.
36. Sanz, E. J, De-Las-Cuevas, C., Kuru, A., et al (2005) Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet, 365, 482-487.
37. Scott, K., Lawrence, R. M., Duggal, A., et al (2002) Prescribing patterns for psychotic and behavioural symptoms in dementia: a national survey. Psychiatric Bulletin, 26, 288-290.
38. Shaw, M. (2001) Competence and consent to treatment in children and adolescents. Advances in Psychiatric Treatment, 7, 150-159.
39. Weiss, E., Hummer, M., Koller, D., et al (2000) Off-label use of antipsychotic drugs. Journal of Clinical Psychopharmacology, 20, 695-698.
40. Williams, L. V., Pearce, G. L., Martin, R. M., et al (1998) The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. British Journal of Obstetrics and Gynaecology, 105, 882-889.
41. Zito, J. M., Safer, D. J., dosReis, S., et al (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA, 283, 1025-1030.
42. Bolam v. Friern Hospital Management Committee [1957] WLR, 582.
43. Bolitho v. City and Hackney Health Authority [1997] 3WLR, 1151.